Professor Sally Ibbotson qualified in Medicine at the University of Leeds in 1986 and, after general medical training, undertook dermatology training in Newcastle upon Tyne where she developed an interest in photodermatology. She was appointed as Clinical Senior Lecturer in Photobiology in the Photobiology Unit, University of Dundee, Ninewells Hospital & Medical School in November 1998. Dr Ibbotson has clinical and research interests in photosensitivity diseases, photodiagnosis, phototherapy and photodynamic therapy

Key areas of research include: skin cancer and photodynamic therapy. phototherapy (notably optimisation of regimes and introduction of new therapies). clinical and genetic determinants of sensitivity and responses to phototherapies for skin diseases. interactions between UV and the skin and photosensitivity disorders.

Dawe RS, Cameron H, Yule S, Ibbotson SH, Moseley H, Ferguson J. A randomized comparison of methods of selecting narrowband UV-B starting dose to treat chronic psoriasis. Arch Dermatol 2011; 147: 168-174 Sarkany RPE, Ibbotson SH, Whatley SD, Clifford ML, Gover P, Mufti GJ, Murphy GM, Masters GS, Badminton MN, Elder GH,. Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria. J Invest Dermatol 2011; 131: 1172-1175 Smith G, Weidlich S, Dawe RS, Ibbotson SH. Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrowband (TL-01) UVB phototherapy. Pharmacogenetics and Genomics 2011; 21: 217-224 Valentine RM, Ibbotson SH, Brown CTA, Wood K, Moseley H. A quantitative comparison of 5-aminolaveulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during PDT. Photochem Photobiol 2011; 87: 242-49 Valentine RM, Brown TAC, Moseley H, Ibbotson S, Wood K. Monte Carlo of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas. J Biomed Optics 2011; 16(4): 048002 Waters AJ, Ibbotson SH. Parameters associated with pain during photodynamic therapy: results of a large Scottish series. Br J Dermatol 2011; 165(3): 693-706 Kerr AC, Ferguson J, Attili SK, Beattie PE, Coleman A, Dawe RS, Eberlein B, Goulden V, Ibbotson SH, Menage H, Moseley H, Novakovic L, Walker SL, Woods JA, Young AR, Sarkany RPE. British Photodermatology Group Workshop Report: UVA phototherapy. An overview and an assessment of its place in Dermatological practice. Clin Exp Dermatol 2011; 36: 541-3 Attili S, Ibbotson SH, Fleming C. Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intraepithelial carcinoma. Photodermatol Photoimmunol Photomed 2011 (in press) Ibbotson SH, Dawe RS, Dinkova-Kostova AT, Weidlich S, Farr PM, Ferguson J, Wolf CR, Smith G. Glutathione S-transferase genotype is associated with sensitivity to psoralen-A (PUVA) photochemotherapy. Br J Dermatol 2011 (in press) McNeilly AD, Harty H, Woods JA, Ibbotson SH, Wolf CR, Smith G. Characterisation of a human keratinocyte HaCaT cell line model to study the regulation of cytochrome P450 CYP2S1. Drug Metabolism and Disposition 2011 (in press)